Clin2
NCT07854405Possibly a fitNot yet recruiting

Chinese herbal granules with standard care for advanced colorectal cancer

Colorectal Cancer

Part of Cancer, Digestive system clinical trials.

This study tests whether adding a traditional Chinese medicine called Zhen-Qi-Jie-Du granules to usual palliative care can improve outcomes for people with advanced colorectal cancer. It aims to see if the combination offers extra benefits without causing more harm.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,540 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You have advanced (stage IV) colorectal cancer that cannot be removed by surgery, or it has come back or spread after surgery.
  • You have not yet received any treatment for metastatic disease (if you are joining the first-line group) OR you have completed or stopped either first-line or second-line treatment due to side effects (for second- or third-line groups).
  • Your cancer is a type called MSS (microsatellite stable), and you have at least one tumor that can be measured on scans.
  • You meet the Traditional Chinese Medicine pattern of spleen-kidney deficiency with internal stasis and toxin.
  • You are between 18 and 80 years old, are physically active (ECOG 0-1), and are expected to live at least 3 months.
  • You can swallow and absorb oral medication, and your liver and kidney function are within normal limits.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03349762Recruiting
Huaier granules to help prevent colorectal cancer coming back

This study tests whether Huaier granules after surgery can lower the chance that colorectal cancer returns or spreads. It is for people who have recently had “radical” (complete) surgery for certain stages of colorectal cancer and are within about 2 months of that surgery.

Shijiazhuang, Hebei
NCT07653685Recruiting· Phase 1/Phase 2
Study of a new drug with chemotherapy for advanced colorectal cancer

This trial tests a new drug (TQB2930) combined with chemotherapy, with or without another drug called bevacizumab, for people whose colorectal cancer has spread or cannot be removed by surgery and has a specific protein called HER2. The goal is to see if this combination can help shrink tumors or slow the cancer's growth.

Beijing, Beijing Municipality
NCT06596343Not yet recruiting· Phase 2
Traditional Chinese medicine after colon cancer surgery

This study tests whether adding traditional Chinese medicine to standard chemotherapy after colon cancer surgery helps patients recover and live longer. If you are between 18 and 75 and have stage III colorectal cancer, this could be an option to discuss with your doctor.

Hangzhou, China
NCT05709249Recruiting· Phase 3
Chinese herbal medicine to help prevent colon cancer return

This Phase 3 study tests whether a Chinese herbal “decoction” (called XLJDOD) given after surgery and chemo can lower the chance that colon cancer comes back. It may help people with higher-risk colon cancer (Stage IIIB or IIIC) stay cancer-free longer.

Nanjing
NCT07129499Not yet recruiting
Herbal granules to prevent high-risk colon polyps from turning into cancer

This trial tests a Chinese herbal medicine called Shenbai Granules to see if it can prevent high-risk colon polyps from turning into cancer. If you have had such a polyp removed and fit the traditional Chinese medicine pattern, you may be able to join.

Nanjing, Jiangsu
NCT07123116Not yet recruiting
Herbal granules to prevent return of low-risk colon polyps

This trial tests whether a traditional Chinese herbal medicine (Shenbai granules) can help stop low-risk colon polyps from coming back after they've been removed. If you've had these polyps taken out, this treatment may offer a way to reduce the chance of new ones growing.

Nanjing, Jiangsu

Hear when a new Colorectal cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.